. . . . . . . . . . . . "a(CHEBI:resveratrol) -| r(RGD:Nos2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The exposure of CAECs to CSE in vitro also elicited the upregulation of iNOS, IL-6, and TNF-a (Fig. 7, A-C). The expression of iNOS, IL-6, and TNF-a in CSE-treated vessels was significantly reduced by resveratrol pretreatment or SIRT1 overexpression (Fig. 7, A-C). The anti-inflammatory effects of resveratrol were significantly attenuated by knockdown of SIRT1 (Fig. 7, A-C)." . . "Selventa" . . . . "2014-07-03T14:33:20.038+02:00"^^ . . .